Teriparatide is a new agent serves as a treatment of choice for severe post-menopausal
osteoporotic patients who are at high risk of fracture or have failed or been intolerant of …

Background: Hip, vertebral and wrist fractures are the most common consequences of
osteoporosis. This study aimed at analyzing the cost-effectiveness of teriparatide …

Objectives: The purpose was to assess the cost effectiveness from a societal perspective of
the recombinant human parathyroid hormones: PTH (1-34)(teriparatide) and PTH (1-84) for …

The demographic and clinical characteristics of patients initiating teriparatide were
compared with those of patients initiating bisphosphonates for the treatment of osteoporosis …

Objective: To describe the study design and baseline patient characteristics of the Asia and
Latin America Fracture Observational Study (ALAFOS) to better understand the profile of …

Until recently, antiresorptive medications such as bisphosphonates and raloxifene
represented the main pharmacological treatment options for patients with osteoporosis. With …

Objective: To compare fractures and fracture-related resource utilization (RU) among
patients with a recent fracture and treated with teriparatide (TPTD) to a matched cohort of …

Purpose The aim of this analysis is to describe the baseline characteristics of patients who
are prescribed teriparatide for the treatment of postmenopausal osteoporosis in a real-world …

The objective of this study was to describe the risk of fragility-related fractures in the 2 years
following teriparatide initiation. In an administrative claims analysis of over 11,407 patients …

Purpose. The efficacy, safety, and cost of teriparatide in the treatment of osteoporosis are
reviewed. Summary. Osteoporosis is a leading cause of fractures in women and men but is …